bromocriptine has been researched along with benztropine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Friedman, JH | 1 |
| Chee, KY; Sachdev, P | 1 |
| Herjanic, M; Schvehla, TJ | 1 |
| Rampertaap, MP | 1 |
| Ackman, D; Etienne, P; Kiely, ME; Lal, S; Thavundayil, JX | 1 |
| Cubeddu, LX; Hoffman, IS | 1 |
| Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ | 1 |
3 review(s) available for bromocriptine and benztropine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differential; Female; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia, Paranoid; Time Factors | 1986 |
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline | 2013 |
2 trial(s) available for bromocriptine and benztropine
| Article | Year |
|---|---|
Pharmacological characterization of tardive akathisia.
Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztropine; Brain; Bromocriptine; Chronic Disease; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Infusions, Intravenous; Male; Metoclopramide; Metoprolol; Physostigmine; Propranolol; Psychomotor Agitation; Schizophrenia, Paranoid | 1990 |
Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects.
Topics: Adult; Apomorphine; Benztropine; Bromocriptine; Cholinergic Fibers; Dopamine; Drug Interactions; Humans; Levodopa; Male; Middle Aged; Penis | 1984 |
4 other study(ies) available for bromocriptine and benztropine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
"Rubral" tremor induced by a neuroleptic drug.
Topics: Adult; Benztropine; Bromocriptine; Corpus Striatum; Fluphenazine; Humans; Male; Neural Pathways; Red Nucleus; Substantia Nigra; Tremor | 1992 |
Neuroleptic malignant syndrome, bromocriptine, and anticholinergic drugs.
Topics: Adult; Benztropine; Bromocriptine; Drug Therapy, Combination; Humans; Male; Muscle Rigidity; Neuroleptic Malignant Syndrome; Tropanes | 1988 |
Presynaptic effects of tetrahydropapaveroline on striatal dopaminergic neurons.
Topics: Animals; Apomorphine; Benztropine; Bromocriptine; Caudate Nucleus; Dopamine; Female; Haloperidol; In Vitro Techniques; Male; Neurons; Papaverine; Putamen; Rabbits; Synapses; Tetrahydropapaveroline | 1982 |